|
Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a …
Wall Street Journal (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for common shares and warrants for … |
